Literature DB >> 23105243

Effect of felodipine on the serum lipid profile of patients with hypertension.

M Kaur1, K Kaur, G K Bedi, G S Sidhu, R Sikand.   

Abstract

Forty patients suffering from mild to moderate degree of hypertension were put on felodipine. Their lipid profile was analysed before the start of their therapy and consecutively at two and four months after starting felodipine. There was a statistically significant fall in the levels of serum cholesterol, serum triglycerides and serum total lipids; though no appreciable variation was observed in HDL and LDL cholesterol levels. At baseline there were a few patients who had higher than the normal range of the serum lipid profile. Analysis of these patients showed a highly significant fall in the levels of serum cholesterol, serum triglycerides, serum LDL-cholesterol and serum total lipids i.e. felodipine modified the lipid profiles of hypertensive patients in a positive way.

Entities:  

Keywords:  Felodipine; Hypertension; Lipid Profile

Year:  2000        PMID: 23105243      PMCID: PMC3453959          DOI: 10.1007/BF02883730

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY.

Authors:  W B KANNEL; T R DAWBER; G D FRIEDMAN; W E GLENNON; P M MCNAMARA
Journal:  Ann Intern Med       Date:  1964-11       Impact factor: 25.391

2.  Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus.

Authors:  L M Lopez; A D Thorman; J L Mehta
Journal:  Am J Cardiol       Date:  1990-11-15       Impact factor: 2.778

3.  Effect of verapamil on serum lipoproteins in patients with angina pectoris.

Authors:  G Walldius
Journal:  Acta Med Scand Suppl       Date:  1984

Review 4.  Treatment of hypertension with calcium channel blockers: European data.

Authors:  W W Klein
Journal:  Am J Med       Date:  1984-10-05       Impact factor: 4.965

5.  Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk.

Authors:  M H Weinberger
Journal:  Am J Med       Date:  1986-02-14       Impact factor: 4.965

6.  Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.

Authors:  N L Lasser; G Grandits; A W Caggiula; J A Cutler; R H Grimm; L H Kuller; R W Sherwin; J Stamler
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

7.  Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.

Authors:  R Misson; T Merkel; R E Cutler
Journal:  Am J Cardiol       Date:  1984-01-27       Impact factor: 2.778

8.  Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

Authors:  O R Etingin; D P Hajjar
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

9.  Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

Authors:  O Stein; E Leitersdorf; Y Stein
Journal:  Arteriosclerosis       Date:  1985 Jan-Feb

10.  Effect of felodipine on serum lipid profile in short term streptozotocin-diabetes in rats.

Authors:  R Jaiprakash; M A Rani; B V Venkataraman; C Andrade
Journal:  Indian J Exp Biol       Date:  1993-03       Impact factor: 0.818

View more
  1 in total

1.  Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals.

Authors:  Huanzi Zhong; Chao Fang; Yanqun Fan; Yan Lu; Bo Wen; Huahui Ren; Guixue Hou; Fangming Yang; Hailiang Xie; Zhuye Jie; Ye Peng; Zhiqiang Ye; Jiegen Wu; Jin Zi; Guoqing Zhao; Jiayu Chen; Xiao Bao; Yihe Hu; Yan Gao; Jun Zhang; Huanming Yang; Jian Wang; Lise Madsen; Karsten Kristiansen; Chuanming Ni; Junhua Li; Siqi Liu
Journal:  Gigascience       Date:  2017-07-01       Impact factor: 6.524

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.